Alaska News Nightly Thursday March 21 2019

first_imgDunleavy keeps open court seat, questions nomination processAssociated PressGov. Mike Dunleavy has declined to fill for now a seat on the Palmer Superior Court, citing questions with the process used in sending nominees to him for consideration.Lawmakers, open meeting advocates criticize conditions on attending Gov. Dunleavy meetingsAndrew Kitchenman, KTOO – JuneauLawmakers and open meeting advocates are criticizing the meetings Governor Dunleavy is holding around the state next week.Dunleavy appointee to lead state environmental agency hits back at criticsElizabeth Harball, Alaska’s Energy Desk – AnchorageJason Brune’s appointment is controversial because he worked as the public affairs and government relations manager for mining company Anglo American when it backed the proposed Pebble Mine.China, Russia find common cause in ArcticLiz Ruskin, Alaska Public Media – Washington D.C.China and Russia are teaming up to pursue their interests in the Arctic, and regional security expert Rebecca Pincus says the United States needs to pay more attention.“We need to play a shaping role in this region. It’s our backyard,” she said.Foretold Disaster – the Exxon Valdez oil spillRachel Waldholz, Alaska’s Energy Desk – AnchorageThe Exxon Valdez oil spill in 1989 killed hundreds of thousands of seabirds and brought commercial fishing in some of Alaska’s most productive waters to a standstill. It’s often talked about as an unprecedented, unthinkable event, but it was, in fact thinkable, and people tried to prevent it.Anchorage efforts to reduce homelessness see success, challengesKirsten Swann, Alaska Public Media – AnchorageAnchorage Assembly member Felix Rivera, chairman of the Assembly’s Committee on Homelessness, says funding is one of its top concernsWild dogs take down muskox near Toksook BayAnna Rose MacArthur. KYUK – BethelJimmie Lincoln wanted to get out of town, so he jumped on his snowmachine and took off. Less than two miles later, he came upon something he calls “unbelievable.”Racist graffiti targets Homer restaurant ownersAaron Bolton, KBBI – HomerThe owners of a restaurant just outside of Homer woke up to racist graffiti scrawled across the front of their building Thursday. The owners of Wasabi’s Bistro reported the incident to police shortly before 8 a.m. and the photos have been shared widely on social media.Eagles fly free as Alaska Raptor Center rings in springEnrique Pérez de la Rosa, KCAW – SitkaMarch 20 is the official start of spring on our calendars. But for the Alaska Raptor Center in Sitka, spring started last Saturday, March 16, when a number of its patients were discharged before an appreciative audience. Stories are posted on the APRN news page. You can subscribe to APRN’s newsfeeds via email, podcast and RSS. Follow us on Facebook at alaskapublic.org and on Twitter @AKPublicNewslast_img read more

French company bungled clinical trial that led to a death and illness

first_imgWhy one man died and four others fell ill during a drug safety study in France last month is still very unclear. But a preliminary inspection report lashes out at Biotrial, the company that conducted the study, for how it responded after the first volunteer in the clinical trial was hospitalized. Three major errors by Biotrial put other volunteers at risk, says the report, published yesterday by France’s General Inspectorate of Social Affairs (IGAS).Biotrial was testing a compound called BIA 10-2474, developed by Portuguese pharma company Bial as a candidate drug for a range of diseases. The study started in July 2015, and initial administrations of the drug produced no severe side effects; things went wrong in a group of eight people who entered the study on 6 January and received multiple, high doses. Six of them were scheduled to receive 10 daily doses of BIA 10-2474, two others a daily placebo. On 10 January, a subject identified as “volunteer 2508” complained of headaches and blurry vision; he was taken to the hospital in the early evening and stayed there overnight.The next morning at 8 a.m., Biotrial staff proceeded to give the seven remaining volunteers their daily dose of BIA 10-2474 or placebo without first finding out how volunteer 2508 was doing. Biotrial apparently assumed his condition wasn’t serious and that he was recovering. “We expected to see him come back,” one staffer told the investigators. “The hospital didn’t call us,” said another. But at 9 a.m., a Biotrial doctor was told by the hospital that the patient’s condition had worsened and that he had been sent to get an MRI. The patient was declared brain-dead later that day, and the study was halted. Four others who had received their doses that day fell ill and subsequently needed hospitalization. Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe The fact that the remaining volunteers weren’t given any information about the status of volunteer 2508 that Monday morning is the second major shortcoming, the report says. As a result, they were unable to reconsider their participation in the study. This violated what Biotrial had promised in an informed consent form: “You will be informed about any new significant information that could affect your willingness to continue the trial.”The third big mistake was not reporting the disaster to the French National Agency for Medicines and Health Products Safety (ANSM) until 14 January, 3 days after Biotrial stopped the study. That made it impossible for ANSM to take measures to protect volunteers who took part earlier or those enrolled in other studies of the same class of molecules.Because BIA 10-2474 works on the body’s endocannibinoid system, it would also have been better to exclude volunteers who regularly use cannabis, the report says, to reduce the risk of any interactions. Biotrial’s exclusion criteria for use of psychoactive substances were inconsistent and not precise enough, the report says. According to the company, however, volunteer 2508 had declared that he didn’t use cannabis; a urine test taken before the trial started had come back negative. The report says more study is needed on this issue.How the other four patients are doing isn’t entirely clear. At a press conference where she presented the report yesterday, French health minister Marisol Touraine said they are improving and have all gone home, but that it’s too soon to say whether they can fully recover. Last month, a doctor who treated them said that three might have irreversible brain damage.The study of BIA 10-2474 had been going on for half a year. Between July 2015 and October 2015, Biotrial tested single doses of the drug on a total of 64 volunteers, with doses increasing from 0.25 to 100 milligrams. After that, 12 volunteers took part in a study that compared a single 40-milligram dose taken on an empty stomach with the same dose combined with a fatty lunch. In November 2015, a series of multiple-dose trials began, each enrolling eight subjects. The first group received 2.5 milligrams daily, the second 5 milligrams, and so on; the accident happened in the fifth group, which received 50 milligrams daily, the highest dose.The 90 people who received BIA 10-2474 earlier have all been contacted; so far, 75 have had a checkup and an MRI, Touraine said yesterday, and all seem fine.IGAS will not present a full report on the matter until March. ANSM is doing its own investigation, as is the public prosecutor’s office in France.Responding to the report, Touraine said that from now on any hospitalization during a clinical trial should be regarded as “new fact” that needs to be brought to the attention of health authorities immediately. Such events should “lead to an immediate suspension of the trial until the safety of volunteers is guaranteed,” she said. “Volunteers must be clearly informed about the suspension of the study and its reasons.” Emailcenter_img Click to view the privacy policy. Required fields are indicated by an asterisk (*) Sign up for our daily newsletter Get more great content like this delivered right to you! Countrylast_img read more